Award

Delivery Order #SPE2DR26FSMH7

Pharmaceutical Tablet Delivery under DMS Pharmaceutical Group IDV Contract

Buyer

Defense Logistics Agency

Award Amount

$3,225.60

Ceiling

$3,225.60

Awarded

February 20, 2026

Period of Performance

Feb 20, 2026 – Feb 23, 2026

Identifier

SPE2DR26FSMH7

NAICS

424210

This contract represents a delivery order awarded to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical product distribution, under an existing indefinite delivery vehicle (IDV) contract aimed at supplying various essential medications. Specifically, the order involves the procurement of IOSAT 130 mg tablets, highlighting the company's role in ensuring the availability of critical pharmaceutical products. The recipient's business focus aligns with supporting public health initiatives by maintaining a steady and reliable supply chain. The contract is significant for the agency as it contributes to uninterrupted access to necessary medications, thereby supporting ongoing healthcare services and public welfare. The scope of work covers the delivery of this specific pharmaceutical product to the designated location in Park Ridge, Illinois, over a concise performance period of a few days in 2026. This delivery order is part of a larger, competitively awarded IDV contract that exemplifies prudent government acquisition practices targeting best value solutions. The contract timeline spans from the award date in early 2026 through the short delivery window. This award builds upon the parent IDV contract initially awarded through competitive bidding, ensuring consistency and reliability in pharmaceutical supplies over multi-year performance.

Description

4571032443!IOSAT 130 MG TABLET 14S

View original record